Serum GDF15 level as predictive biomarker of clinical outcome in patients with unresectable hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy

Serum GDF15 level as predictive biomarker of clinical outcome in patients with unresectable hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy

BackgroundHepatic arterial infusion chemotherapy (HAIC) using the FOLFOX regimen has been explored for unresectable hepatocellular carcinoma (HCC) patients, yet predictive biomarkers are lacking. This study aimed to evaluate the potential of serum growth differentiation factor 15 (GDF15) as a biomar...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rui Xing, Junyu Gan, Jie Mei, Zhixiong Li, Jing Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	growth differentiation factor 15 hepatocellular carcinoma hepatic arterial infusion chemotherapy serum biomarker overall survival progression-free survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1619387/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and factors related to prognosis of combination chemotherapy with different radiotherapy methods in patients with unresectable hepatocellular carcinoma
by: Lian-Qiang Han
Published: (2025-04-01)

Anxiety is a risk prognosis factor for hepatocellular carcinoma with portal vein tumor thrombus who underwent hepatic arterial infusion chemotherapy: a propensity score-matching cohort study
by: Hao-yang Tan, et al.
Published: (2025-05-01)

Retrospective Multicentre Real-Life Study Evaluating the Efficacy of Atezolizumab Combined with Bevacizumab for the Treatment of Metastatic Hepatocellular Carcinoma: HIREAL Study
by: Barbe-Richaud JB, et al.
Published: (2025-07-01)

Hepatic Artery Infusion Chemotherapy for Hepatocellular Carcinoma: Clinical Advancements
by: Wei Xu, et al.
Published: (2025-05-01)

Preoperative serum inflammatory markers in the prognostic assessment of hepatocellular carcinoma resection in stages I/II
by: Fan Liu, et al.
Published: (2025-08-01)

Survival outcomes after surgical resection of huge HCC (≥ 10 cm) with or without neoadjuvant hepatic arterial infusion chemotherapy
by: Chia-Ling Chiang, et al.
Published: (2025-06-01)

Hepatic Arterial Infusion Chemotherapy Combined Apatinib/Camrelizumab for Recurrent Hepatocellular Carcinoma After Hepatectomy
by: Zheng X, et al.
Published: (2025-06-01)

Hepatic arterial infusion chemotherapy in patients with unresectble hepatocellular carcinoma: 3-year survival update
by: Shiguang Chen, et al.
Published: (2025-12-01)

Coilin Affects the Prognosis of Hepatocellular Carcinoma Through Cell Cycle and Apoptosis
by: Lu L, et al.
Published: (2025-02-01)

Experience of using chemotherapy treatment for the first recurrence of ovarian cancer
by: V. N. Zhurman
Published: (2025-01-01)

Transarterial chemoembolization plus apatinib for unresectable hepatocellular carcinoma: a multicenter, randomized, open-label, phase III trial
by: Xue-Feng Kan, et al.
Published: (2025-05-01)

Refining Intra-Arterial Therapy Selection for Large Hepatocellular Carcinoma: A Deep Learning Approach Based on Covariate Interaction Analysis
by: An C, et al.
Published: (2025-07-01)

Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)Research in context
by: Wei Gao, et al.
Published: (2025-05-01)

Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center
by: Ted Kim, et al.
Published: (2025-03-01)

Transient hepatic intensity differences: correlations with treatment outcomes and adverse events following DEB-TACE in hepatocellular carcinoma
by: Noble Chibuike Opara, et al.
Published: (2025-08-01)

Survival benefit of conversion surgery after intravenous 5-fluorouracil-based chemotherapy in unresectable advanced gastric cancer: a retrospective cohort study
by: Peticha Tanprasert, et al.
Published: (2025-07-01)

Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving lenvatinib: a retrospective, multicenter cohort study
by: Yitao Zheng, et al.
Published: (2025-07-01)

Exploring the effects of doxorubicin on survival rates in glioma patients: a comprehensive systematic review
by: Elyar Mahboubi, et al.
Published: (2025-05-01)

Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial
by: Chang Yin, et al.
Published: (2025-07-01)

Factor Analysis of the Effect of Hepatitis B-Related Liver Cancer Treatment Efficacy
by: Liu SW, et al.
Published: (2025-06-01)

The effect of postoperative chemotherapy on blood glucose and prognosis in patients with advanced ovarian cancer
by: Ting Du, et al.
Published: (2025-01-01)

The incidence of malignant tumors in patients with liver cirrhosis and the impact of the development of hepatocellular carcinoma on the overall survival of patients with cirrhosis
by: Vladislav V. Petkau, et al.
Published: (2024-03-01)

The association between neutrophil percentage to albumin ratio and progression-free survival and overall survival in colorectal cancer patients: a retrospective cohort study
by: Hailun Xie, et al.
Published: (2025-07-01)

The role of Lobectomy in Glioblastoma management: A Retrospective series
by: Christina K. Arvaniti, et al.
Published: (2025-01-01)

Predictors of recurrence after conversion therapy in unresectable hepatocellular carcinoma treated with HAIC, bevacizumab, and sintilimab
by: Chang-Fu Liu, et al.
Published: (2025-08-01)

Hepatic arterial infusion chemotherapy (HAIC) plus Lenvatinib and PD-1 inhibitors versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma
by: Qingyu Xu, et al.
Published: (2025-05-01)

Prognostic value of residual cancer burden after neoadjuvant chemotherapy in breast cancer: a comprehensive subtype-specific analysis
by: Soo-Young Lee, et al.
Published: (2025-04-01)

Hepatic arterial infusion chemotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a meta-analysis of survival outcomes
by: Di Zeng, et al.
Published: (2025-07-01)

Comparison of AI chatbot predicted and realworld survival outcomes in hepatocellular carcinoma
by: Engin Eren Kavak, et al.
Published: (2025-07-01)

Prediction of prognosis of immune checkpoint inhibitors combined with anti-angiogenic agents for unresectable hepatocellular carcinoma by machine learning-based radiomics
by: Xuni Xu, et al.
Published: (2025-05-01)

Exploring the association between chemotherapy and prognosis among patients less than 50 years old with hepatocellular carcinoma: a retrospective cohort study based on the SEER database
by: Qiyu Zhang, et al.
Published: (2025-05-01)

Clinical and Survival Insights into Carcinoma Penis: A Retrospective Analysis at a Tertiary Care Facility
by: Santosh Kumar Swain, et al.

Prognostic value of sarcopenia in patients with unresectable colorectal liver metastases after drug-eluting beads transcatheter arterial chemoembolization: a single center retrospective study
by: Fuquan Wang, et al.
Published: (2025-04-01)

Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02)
by: Hang Yuan, et al.
Published: (2025-07-01)

Thrombotic events in patients with multiple myeloma and their impact on overall survival
by: Haimin Chen, et al.
Published: (2025-12-01)

EXPRESSION OF CANCER-TESTIS GENES PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 IN PATIENTS WITH MULTIPLE MYELOMA, THEIR INFLUENCE ON OVERALL SURVIVAL AND RELAPSE RATE
by: A. A. Solodovnik, et al.
Published: (2018-07-01)

Transarterial intervention therapy plus systemic therapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
by: Zelong Liu, et al.
Published: (2025-09-01)

Nomogram prediction of overall survival in patients with bone metastases from hepatocellular carcinoma: a SEER-based retrospective cohort study
by: Qingliang Song, et al.
Published: (2025-07-01)

Development, verification, and comparison of a risk stratification model to identify potential population benefiting from chemotherapy in non-metastatic male breast cancer
by: Mingkun Zhang, et al.
Published: (2025-07-01)

Prognostic significance of circulating tumor DNA detection and quantification in cervical cancer: a systematic review and meta-analysis
by: Xiumin Zhao, et al.
Published: (2025-04-01)